BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37425605)

  • 21. Influence of residual platelet count on routine coagulation, factor VIII, and factor IX testing in postfreeze-thaw samples.
    Lippi G; Rossi R; Ippolito L; Zobbi V; Azzi D; Pipitone S; Favaloro EJ; Funk DM
    Semin Thromb Hemost; 2013 Oct; 39(7):834-9. PubMed ID: 24022807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels.
    Alesci S; Borggrefe M; Dempfle CE
    Thromb Res; 2009 May; 124(1):121-6. PubMed ID: 19128820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stability of 'add-on' coagulation assays in refrigerated citrated plasma stored on a packed cellular fraction.
    Quirke W; Toomey S; Sheikhi A
    Int J Lab Hematol; 2021 Aug; 43(4):779-785. PubMed ID: 33991057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
    Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
    J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity.
    Zhao Y; Feng G; Zhang J; Gong R; Cai C; Feng L
    Sci Rep; 2017 Sep; 7(1):12179. PubMed ID: 28939816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
    Tseng LW; Hughes D; Giger U
    Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
    De Kam PJ; Grobara P; Prohn M; Höppener F; Kluft C; Burggraaf J; Langdon RB; Peeters P
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):227-36. PubMed ID: 24447651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of capillary and venous blood sampling for routine coagulation assays.
    Fliervoet LAL; Tiel Groenestege WM; Huisman A
    Clin Biochem; 2022 Jun; 104():30-35. PubMed ID: 35123976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation Factor Activities Changes Over 5 Days in Thawed Fresh Frozen Plasma Stored at Different Initial Storage Temperatures.
    Noordin SS; Karim FA; Mohammad WMZBW; Hussein AR
    Indian J Hematol Blood Transfus; 2018 Jul; 34(3):510-516. PubMed ID: 30127563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of artificial colloids on blood coagulation during shock stage of severe burn injury.
    Zhou JJ; Xing N; Chen J; Shi JW; Su GL
    Chin Med J (Engl); 2013; 126(17):3334-9. PubMed ID: 24033960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of isotretinoin on prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT).
    Kaptanoglu AF; Uncu M; Ozyurt S; Hincal E
    J Dermatolog Treat; 2013 Aug; 24(4):272-4. PubMed ID: 22188511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Analytical Properties of the Diagon CoagXL Coagulation Analyzer.
    Koç H; Yildiz Z; Hürmeydan Ö; Madenci ÖÇ; Yücel N; Orçun A
    Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
    Tschaikowsky K; Balint R; Pscheidl E; Bremer F
    Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Preanalytical Variables on Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen.
    Kim H; Kim Y; Lee HK
    Clin Lab; 2015; 61(9):1337-40. PubMed ID: 26554255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid dry plasma thawing system: An alternative to conventional thawing baths.
    Pinki SS; Mohan G; Rafi AM; Innah SJ; Thomas T
    Asian J Transfus Sci; 2017; 11(2):147-150. PubMed ID: 28970683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of experimental hypercalcemia on routine haemostasis testing.
    Lippi G; Salvagno GL; Brocco G; Gelati M; Danese E; Favaloro EJ
    PLoS One; 2017; 12(3):e0175094. PubMed ID: 28362859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation factors V, VIII, and X, prothrombin time and activated partial thromboplastin time test results in thawed plasma stored at 1-6 ºC for 5 days.
    Naghadeh HT; Maghsudloo M; Tabatabaei MR
    Blood Transfus; 2011 Jan; 9(1):95-8. PubMed ID: 21235855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®.
    Ver Elst K; Vermeiren S; Schouwers S; Callebaut V; Thomson W; Weekx S
    Int J Lab Hematol; 2013 Dec; 35(6):614-9. PubMed ID: 23663653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.